Clinical Trial Update: RIvaroxaban for Valvular Heart diseasE and atRial Fibrillation Trial -RIVER Trial [Phase 2]

View source ↗

Summary

Phase 2 trial update for rivaroxaban in valvular heart disease with atrial fibrillation (RIVER trial) has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Atrial Fibrillation
• Valvular Heart Disease

Drugs mentioned

• Rivaroxaban (rivaroxaban)

Snippet

Sponsor: Hospital do Coracao | Conditions: Valvular Heart Disease | Phase 2 | Status: COMPLETED